Compare Intel Corp (INTC) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intel Corp vs Health Care Select Sector SPDR Fund — how do they compare? Intel Corp trades at $104.7 (market cap $566.04B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Intel Corp is far larger — about 13× Health Care Select Sector SPDR Fund's market cap, and Intel Corp pays a 2.24% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intel Corp for 116 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| INTC | XLV | |
|---|---|---|
Market Cap | $566.04B | $43.48B |
Volume | 118,475,837 | 11,121,431 |
Sector | Technology | — |
52-Week High | $140.94 | $175.68 |
52-Week Low | $33.62 | $141.95 |
Typical Hold Time | 116 Days | 100 Days |
Enterprise Value | $586.85B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intel (INTC) trades at $107.08, down 5.34% over 24 hours, with a bullish technical breakout pattern despite near-term bearish momentum indicators. The company reported three consecutive quarterly EPS beats but posted a net loss of -$267 million in 2025, with revenue declining to $52.85 billion. Intel Foundry's 31% year-over-year growth in Q2 2026 and High-NA chipmaking progress highlight its strategic pivot, though profitability remains challenged with a negative net margin of -0.51%.
Intel's outlook balances a 222% stock surge in 2026 against high valuation multiples and persistent margin pressures. Investment opportunities lie in its foundry turnaround and AI infrastructure positioning, but risks include intense competition, execution challenges, and debt levels. Analyst consensus is cautious with a $111.72 price target and 54% hold ratings, signaling wait-and-see sentiment amid volatile fundamentals.
XLV trades at $170.81, up 1.18% with a bearish technical signal from moving averages. The ETF's low 0.08% expense ratio and healthcare sector diversification provide defensive positioning amid market volatility. Recent options activity shows increased put volume, indicating some investor caution despite healthcare's traditional defensive characteristics during economic uncertainty.
Healthcare sector ETFs like XLV offer defensive exposure with potential upside from demographic trends and innovation. Key risks include political volatility around healthcare policy and concentration in large-cap US stocks. The ETF's cost efficiency and sector positioning make it attractive for long-term investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
